Genetic Analysis
0.78 NOK
+2.63 %
Less than 1K followers
GEAN
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
+2.63 %
-1.89 %
-9.30 %
-14.29 %
+52.94 %
+41.82 %
-67.50 %
-
-92.71 %
Genetic Analysis operates in the medical technology sector. The company conducts research and development in the field of diagnostics, with the greatest focus on the human microbiome. The technology is based on the company's research platform and the IVD products are used, for example, for testing and analysis of bacteria and viruses. The largest operations are found in the Nordic market and the products are mainly resold to laboratories. The company is headquartered in Oslo, Norway.
Read moreMarket cap
53.89M NOK
Turnover
477.36 NOK
Revenue
15.89M
EBIT %
-89.49 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
25.2
2026
Annual report '25
All
Press releases
3rd party
ShowingAll content types
Genetic Analysis AS announces milestone in the IBD diagnostic test development project - completion of biomarker panel for GA-map® IBD Precision Dx
Genetic Analysis AS launches the GA-map® MHI GutHealth reagent kit
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools